
GlaxoSmithKline faces fresh allegations that it bribed Syrian doctors and officials to boost sales of its medicines in what is …

GlaxoSmithKline posted a 4% slide in revenue for the second quarter today as its recovery from a slew of patent …

The man who GlaxoSmithKline paid to investigate an illegally produced sex tape of one its senior employees has been charged …

The woes of GlaxoSmithKline look set to continue as the UK’s Serious Fraud Office (SFO) has launched a criminal probe …

A British man who headed-up GlaxoSmithKline’s troubled China business has been charged with two other executives on charges of bribery …

Poland has become the latest country in a string of bribery claims to hit GSK as it faces legal action …

A former sales representative for GlaxoSmithKline has spoken of the firm’s alleged tactics in bribing poorly paid doctors in China …

The boss of generic drug manufacturer Actavis says his company is pulling out of China because the business environment there …


GlaxoSmithKline is to remove individual staff sales targets and end doctor payments for activities that promote its products. The UK …

Prime minister David Cameron has defended London-based pharma giant GlaxoSmithKline over its treatment in China during a visit to the …

GlaxoSmithKline chief executive Sir Andrew Witty has embarked on a potentially delicate diplomatic mission as part of a UK trade …

GlaxoSmithKline is unlikely to face a company-wide charge for corruption following investigations by authorities in China according to reports. The …

GlaxoSmithKline has refuted reports that its former chief of Chinese operations is barred from leaving the country while he assists …